• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cochlear launches iOS-connectable Nucleus 7 cochlear implant

Cochlear launches iOS-connectable Nucleus 7 cochlear implant

July 26, 2017 By Fink Densford

Cochlear Ltd.

Cochlear Ltd. (ASX:COH) today launched its Nucleus 7 sound processor cochlear implant, touting it as the smallest and lightest behind-the-ear implant sound processor available.

The Sydney-based company said that the newly launched Nucleus 7, which won FDA clearance last month, is the 1st cochlear implant designed to connect directly with Apple (NSDQ:AAPL) iOS devices, allowing individuals to stream sound from their compatible devices.

The Nucleus 7 will also allow users to control, monitor and customize their hearing on their attached smart device, the company said.

“The approval of the Nucleus 7 Sound Processor is a turning point for people with hearing loss, opening the door for them to make phone calls, listen to music in high-quality stereo sound, watch videos and have FaceTime calls streamed directly to their cochlear implant. This new sound processor builds on our long-standing commitment to help more people with hearing loss connect with others and live a full life,” CEO Chris Smith said in a prepared release.

The newly launched Nucleus 7 offers a hearing tracker feature which records coil-off time and time in speech, as well as an application to locate lost sound processors using location services. The system can also be used in combination with a hearing aid with synchronized streaming to both ears, the company said.

“Technology that offers greater connectivity seeks to make life easier for people with hearing loss. The advancements provided by the Nucleus 7 Sound Processor give parents more control and allow them to better monitor their child’s hearing while adults and teenagers will be able to stream music and make FaceTime calls just like their hearing friends and family,” Laurel Mahoney of the NYU Langone Medical Center said in a prepared statement.

The device is expected to be commercially available in September in the US and Canada, with options to upgrade to the device in October for individuals using the Nucleus CI24RE, CI500 and Profile Series implants, Cochlear said.

“The ability to control both hearing solutions through an iPhone or iPod touch and provide a seamless hearing experience between them is a remarkable technological step forward. At Cochlear, we design devices to give recipients greater flexibility to personalize their settings and manage their hearing loss on a daily basis, and these new solutions offer that experience like never before,” R&D senior VP Jan Janssen said in a press release.

Filed Under: Business/Financial News, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Cochlear Ltd.

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy